Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
Add more filters










Publication year range
4.
Med Clin (Barc) ; 97(12): 459-62, 1991 Oct 12.
Article in Spanish | MEDLINE | ID: mdl-1753816

ABSTRACT

The clinical observation of a 74 year old male presenting isolated Wernicke's aphasia due to a temporal left infarction of cardiac embolic origin secondary to paroxysmal auricular flutter is described. Transthoracic and transesophageal echocardiography, computerized tomography and magnetic resonance provided characteristic images which permitted the establishment of the diagnosis of lipomatous hypertrophy of the interauricular septum without requiring the use of invasive techniques. Lipomatous hypertrophy of the interauricular septum is a cardiac tumor of unusual presentation constituted of an abnormal accumulation of non-encapsulated fatty tissue which occupies a thickness greater than 15 mm of the interauricular septum. Wernicke's aphasia as a form of presentation of the lipomatous hypertrophy of the interauricular septum has not previously been described in the literature.


Subject(s)
Aphasia, Wernicke/etiology , Heart Neoplasms/complications , Intracranial Embolism and Thrombosis/etiology , Aged , Aphasia, Wernicke/diagnosis , Atrial Flutter/complications , Atrial Flutter/diagnosis , Atrial Flutter/etiology , Brain/diagnostic imaging , Heart Neoplasms/diagnosis , Heart Septum/pathology , Humans , Hypertrophy/complications , Hypertrophy/diagnosis , Intracranial Embolism and Thrombosis/complications , Intracranial Embolism and Thrombosis/diagnosis , Lipoma/complications , Lipoma/diagnosis , Male , Radiography
5.
Rev Esp Cardiol ; 43(6): 408-9, 1990.
Article in Spanish | MEDLINE | ID: mdl-2236787

ABSTRACT

Syncope is a rare presentation of glossopharyngeal neuralgia (GN). A patient with squamous cell cancer of the pharynx had GN and syncope due to asystolic pauses and extreme hypotension. The bradyarrhythmias were atropine-sensible, but both this treatment and pacing failed to prevent recurrence of syncopal hypotensive crises, blood pressure continuing to fall during GN attacks. These data suggest that during a neuralgic attack the stimulation excites vagi, causing asystole, and simultaneously abolishes sympathetic tone. Carbamazepine was effective in controlling the symptoms of the patient.


Subject(s)
Glossopharyngeal Nerve/physiopathology , Hemodynamics/physiology , Neuralgia/etiology , Syncope/etiology , Carbamazepine/therapeutic use , Carcinoma, Squamous Cell/complications , Humans , Hypotension/complications , Male , Middle Aged , Neuralgia/physiopathology , Pharyngeal Neoplasms/complications , Syncope/drug therapy , Syncope/physiopathology
8.
Antimicrob Agents Chemother ; 34(2): 321-5, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2109579

ABSTRACT

A regimen of a single intramuscular dose of penicillin G-streptomycin was compared with regimens of three oral doses of amoxicillin and two oral doses of penicillin V to prevent Streptococcus sanguis endocarditis in rabbits with experimentally induced valvular heart lesions. Challenge doses of 10(4), 10(6), and 10(8) CFU of a strain of S. sanguis highly tolerant to penicillin and amoxicillin were used. The combination of penicillin and streptomycin was the only regimen tested that provided full protection even against the highest inoculum concentration. A single oral dose of penicillin V (36 mg/kg) or amoxicillin (50 mg/kg), two oral doses of penicillin V (36 and 18 mg/kg with a 7-h interval between doses), or six oral doses of amoxicillin (50 mg/kg followed by 8.5 mg/kg at 8-h intervals) protected recipients of the lowest inoculum concentration; protection diminished with increasing inocula. In contrast, administration of two high oral doses of amoxicillin (50 mg/kg) with a 10-h interval between doses provided full protection against challenge doses of 10(4) and 10(6) CFU, preventing endocarditis in 10 (66%) of 15 recipients of 10(8) CFU. All regimens evaluated were highly effective in preventing endocarditis when rabbits were challenged with 10(4) CFU. The combination of penicillin and streptomycin was the best regimen tested. Administration of two high oral doses of amoxicillin (50 mg/kg) with a 10-h interval between doses led to significantly fewer infections when compared with the other oral regimens when rabbits were challenged with 10(6) and 10(8) CFU.


Subject(s)
Amoxicillin/pharmacology , Endocarditis, Bacterial/drug therapy , Penicillin V/pharmacology , Penicillins/pharmacology , Streptococcal Infections/drug therapy , Streptomycin/pharmacology , Amoxicillin/administration & dosage , Amoxicillin/therapeutic use , Animals , Drug Therapy, Combination/pharmacology , Drug Therapy, Combination/therapeutic use , Endocarditis, Bacterial/microbiology , Microbial Sensitivity Tests , Penicillin G/pharmacology , Penicillin V/administration & dosage , Penicillin V/therapeutic use , Penicillins/administration & dosage , Penicillins/therapeutic use , Rabbits , Streptococcal Infections/microbiology , Streptococcus sanguis/drug effects , Streptomycin/administration & dosage , Streptomycin/therapeutic use
11.
Antimicrob Agents Chemother ; 31(10): 1474-7, 1987 Oct.
Article in English | MEDLINE | ID: mdl-3124728

ABSTRACT

Four oral penicillin V regimens were compared for the ability to prevent Streptococcus sanguis infection of experimentally induced valvular heart lesions in rabbits. Challenge doses of 10(4), 10(6), and 10(8) CFU of a penicillin-susceptible strain of S. sanguis were used in this study. Measured by recovery of test organisms from endocardial lesions, the lowest-concentration inoculum was infective for 53% of the recipients; the higher-concentration inocula were infective for all recipients. A single-oral-dose penicillin V regimen (36 mg/kg of body weight) prevented endocarditis when rabbits were challenged with 10(4) CFU, but protection diminished with increasing inoculum concentrations. In contrast, addition of a second penicillin V dose (18 mg/kg of body weight) administered with a 7-h interval between doses achieved fully effective prophylaxis against even the highest inoculum tested (10(8) CFU). A repeated set of experiments in which half the dose of penicillin V was administered showed significantly reduced protection against S. sanguis endocarditis.


Subject(s)
Endocarditis, Bacterial/prevention & control , Penicillin V/therapeutic use , Streptococcal Infections/prevention & control , Adult , Animals , Female , Humans , Male , Microbial Sensitivity Tests , Penicillin V/blood , Penicillin V/pharmacology , Rabbits , Streptococcus sanguis/drug effects
19.
Antimicrob Agents Chemother ; 29(5): 909-12, 1986 May.
Article in English | MEDLINE | ID: mdl-3729348

ABSTRACT

A single-intramuscular-dose immunization regimen with a penicillin G-streptomycin combination was compared with three oral-dose amoxicillin regimens for the capacity to prevent Streptococcus sanguis infections of experimentally induced valvular heart lesions in rabbits. Challenge doses of 10(4), 10(6), and 10(8) CFU of a strain of S. sanguis equally susceptible to penicillin and amoxicillin were used in this study. Measured by recovery of test organisms from endocardial lesions, the lowest concentration of these inocula was infective for 60% of the recipients; the two higher-concentration inocula were infective for all recipients. The penicillin G-streptomycin combination provided complete protection against infection with inocula of all sizes. A single-oral-dose amoxicillin regimen (50 mg/kg of body weight) prevented endocarditis when rabbits were challenged with 10(4) CFU, but protection diminished with increasing inoculum concentrations. Similar results were achieved when five oral doses of amoxicillin (8.5 mg/kg of body weight) added at 8-h intervals were included in the single-oral-dose regimen. In contrast, when rabbits received two oral doses of amoxicillin (50 mg/kg of body weight) with a 10-h interval between doses, prophylaxis was fully effective with even the highest inoculum concentration.


Subject(s)
Amoxicillin/therapeutic use , Endocarditis, Bacterial/prevention & control , Penicillin G/therapeutic use , Streptococcal Infections/prevention & control , Streptomycin/therapeutic use , Amoxicillin/administration & dosage , Amoxicillin/blood , Animals , Drug Therapy, Combination , Humans , Penicillin G/administration & dosage , Penicillin G/blood , Rabbits , Species Specificity , Streptococcus sanguis , Streptomycin/administration & dosage , Streptomycin/blood , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...